Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.11% to 8777.39, DAX +0.58% to 22037.83, CAC40 +0.28% to 8028.90, STOXX 600 +0.23% to 547.18

Feb 11 ,2025

  • Synopsis:

    • European equity markets ended mixed with pan-European indices around closing session highs. Netherlands +0.8% , Switzerland +0.6% and Spain +0.5% led outperformers whilst Denmark (0.5%), Portugal and Greece (0.2%) led underperdormers.

    • Focus on commentary about potential impact of US tariffs in wake of Trump's latest salvo. FT said European companies bracing for uncertainty fuelled by a global trade war that will lead to policies affecting investments. Cited utilities executives warning tariff threats are slowing renewable energy projects in the US. Added that while some corporates seek to expand in the US markets, analysts stress that uncertainty, not just tariffs, is hurting growth.

    • EU trade ministers set to hold a video conference on 12-Feb following Trump's decision (Politico). EU Commission President von der Leyen vowed to take firm and proportionate actions (Politico). Reports that UK PM Starmer to meet Trump before end of February. The London Times reported Britain is not expected to join the EU in retaliating against Trump steel tariffs and hopes to negotiate an opt-out from proposed 25% levy.

    • Central bank narrative also in focus. BoE member Mann, former hawk who voted for 50 bps cut, said demand conditions quite a bit weaker and expects companies to struggle to raise prices. In the UK, survey from British Retail Consortium showed fastest increase in consumer spending in two years in January, offering some hope to beleaguered retail sector. Meanwhile, EU gas storage levels in focus with prices climbing to two-year highs on cold weather. Elsewhere, France said it will keep its digital tax despite risk of retaliation.

    • In a busy earnings session, Kering (KER.FP) revenue beat in Q4 and FY, with Gucci underperforming with comparable change (24%) vs SA (23.3%). In the DACH region, ams-OSRAM (AMS.SW) shares gained as much as +19% following robust Q4 results. SGS (SGSN.SW) also higher following in line FY earnings and better FY25 operating margin guide. Suedzucker (SZU.GR) now expects FY Group EBITDA and operating result at the upper area of guidance ranges; provides initial guidance for FY26. Backing the trend, TUI Group (TUI1.GR) shares are down despite solid Q1 beat for revenue and EBIT; analysts note reiterated guidance suggest slow-down in EBIT growth rates for the rest of the year and also point out winter 2024/25 volumes are +2% vs +4% reported in Dec update.

    • In the UK, BP (BP.LN) posted mixed Q4 earnings with focus turning to strategy reset to be announced at capital markets event on 26-Feb. Dunelm Group (DNLM.LN) reported H1 with special dividend of 35p/sh also announced along with retirement of CEO. Bellway (BWY.LN) H1 2025 trading update showed strong performance, with completions up 11.9% to 4,577 homes and a private sales rate increase of 18.6% to 0.51.

    • In Italy, UniCredit (UCG.IM) shares traded lower despite better-than-expected Q4 numbers with FY25 guidance of net profit and RoTE broadly in line with FY24 despite macro headwinds. Mediobanca (MB.IM) was higher following better-than-expected Q2 results and reaffirmed FY25 guidance and raised FY26 targets.

    • On M&A front, Merck KGaA (MRK.GR) confirmed discussions to acquire SpringWorks Threapeutics (SWTX). Novartis (NOVN.SW) to acquire Anthos Therapeutics for $925M up front with potential additional payments of up to $2.15B upon achievement of specified regulatory and sales milestones. dsm-firmenich (DSFIR.NA) to sell stake in Feed Enzymes Alliance to Novonesis (NSIS.B.SS) for €1.5B. Portugal reportedly considering sale of at least 49% of airline TAP.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Banks +1.29%, Oil & Gas +0.80%, Ind Goods & Svcs +0.77%, Technology +0.74%, Media +0.43%, Telecom +0.41%, Retail +0.38%, Autos & Parts +0.32%

      • Underperformers

        • Travel & Leisure (2.35%), Basic Resources (1.86%), Utilities (0.92%), Real Estate(0.72%), Health Care (0.67%), Chemicals (0.14%), Insurance (0.06%), Financial Svcs (0.02%), Persnl & HHold Goods +0.04%, Construct & Mtls +0.06%, Food & Beverage +0.10%

    • Macro/Peripheral markets:

      • EU

        • Speech by EU's von der Leyen at the Artificial Intelligence Action Summit (release)

        • EU launches InvestAI initiative to mobilise €200B of investment in artificial intelligence (release)

        • EU to retaliate against US steel and aluminium tariffs (FT)

        • European gas prices spike to 2-year highs as storage levels falter (Euronews )

      • Central Banks

        • ECB's Kazaks urges EU-US trade talks to avert tariff war (Bloomberg)

        • BoE's ex-hawk Mann calls for aggressive rate cuts amid weakening demand (FT)

        • Are we underestimating changes in financial markets? - speech by Andrew Bailey (release )

      • Geopolitics

        • Trump administration urges Europe to buy American weapons for Ukraine ahead of peace talks (Reuters)

        • Trump's envoy to present options for ending Ukraine war in weeks (Bloomberg)

        • Statement on U.S. steel tariffs by EUROFER President, Dr. Henrik Adam (release )

      • UK

        • Social media trends drive retail sales surge in January (Guardian)

        • UK seeks talks to avoid Trump's steel and aluminum tariffs (Bloomberg)

        • Starmer to meet Trump in Washington amidst trade tensions (Telegraph)

        • The February 2025 Monetary Policy Report, Catherine L. Mann speech - BoE release

        • New UK sanctions target Russian cybercrime network (gov.uk )

      • Spain

        • Spain pushes to double EU budget to over €2 trillion (Politico)

      • Greece

    • Company news:

      • Notable Gainers

        • +18.7% AMS.SW (ams-OSRAM CHF8.09, +1.28) -- Q4 earnings

        • +17.2% BEN.FP (Beneteau €10.18, +1.50) -- prelim FY earnings; CIC Market Solutions and Gilbert Dupont upgrades

        • +15.1% BAR.BB (Barco €11.11, +1.46) -- FY earnings

        • +11.6% RLF.SW (RELIEF THERAPEUTICS Holding CHF3.46, +0.36) -- European Patent Office decision to grant patent for RLF-TD011

        • +8.2% SVED.B.SS (Svedbergs Group SEK48.50, +3.70) -- Q4 earnings

        • +8.1% RWS.LN (RWS Holdings £1.52, +0.11) -- AGM statement

        • +7.6% PACT.SS (Proact IT Group SEK130.40, +9.20) -- Q4 earnings

        • +6.8% WHA.NA (Wereldhave €16.06, +1.02) -- FY earnings

        • +6.7% SGSN.SW (SGS CHF97.28, +6.12) -- FY earnings

        • +6.2% PSAN.GR (PSI Software €24.00, +1.40) -- company and E.ON jointly implement intelligent control system for the distribution grid of the future

        • +4.9% PZC.LN (PZ Cussons £0.83, +0.04) -- H1 earnings

        • +3.9% TLT1V.FH (Teleste €2.90, +0.11) -- Q4 earnings

        • +3.6% ALO.FP (Alstom €21.13, +0.73) -- Alstom and Deutsche Bahn sign long-term framework contract for the modernisation and digitalisation of the German rail network; contract value > €600M

        • +3.3% EQNR.NO (Equinor NOK281.50, +9.00) -- HSBC upgrade

        • +3.0% BEIA.B.SS (Beijer Alma SEK193.00, +5.60) -- acquires International Industrial Springs

        • +2.7% LATO.B.SS (Latour Investment SEK296.30, +7.80) -- Q4 earnings

        • +2.3% BRAV.SS (Bravida Holding SEK92.35, +2.10) -- Q4 earnings

        • +2.2% LIFCO.B.SS (Lifco SEK387.40, +8.40) -- initiated buy at UBS

        • +1.9% MOVE.SW (Medacta Group CHF137.00, +2.60) -- initiated buy at Bryan Garnier

        • +1.7% FNTL.LN (Fintel £2.69, +0.04) -- transitions to single CEO structure

        • +1.6% ALVU.FP (Vente-Unique.com €13.10, +0.20) -- Q1 revenue

        • +1.4% KER.FP (Kering €247.90, +3.50) -- FY earnings

        • +1.4% BOUL.SS (Boule Diagnostics SEK8.82, +0.12) -- Q4 earnings

        • +1.4% DUNI.SS (Duni SEK103.20, +1.40) -- Q4 earnings

        • +1.4% LAGR.B.SS (Lagercrantz Group SEK234.20, +3.20) -- completes acquisition of TASL in the UK

      • Notable Decliners

        • -21.2% LAND.SW (Landis+Gyr Group CHF49.65, -13.35) -- to discontinue the EV charging business and record impairment as well as restructuring charges in relation to this decision; lowers FY24 guidance

        • -14.2% CTM.SS (Catena Media SEK4.13, -0.68) -- Q4 earnings

        • -13.9% MOB.SS (Moberg Pharma SEK8.23, -1.33) -- Q4 earnings

        • -10.4% TUI1.GR (TUI Group €7.64, -0.89) -- Q1 earnings

        • -10.3% ENT.LN (Entain £6.63, -0.77) -- CEO steps down

        • -8.1% KEMIRA.FH (Kemira €20.06, -1.76) -- Q4 earnings

        • -5.7% BWY.LN (Bellway £24.20, -1.46) -- trading update

        • -5.5% STERV.FH (Stora Enso €9.79, -0.57) -- Q4 earnings

        • -4.7% IPCO.SS (International Petroleum Corp SEK143.90, -7.10) -- Q4 earnings

        • -3.6% WIHL.SS (Wihlborgs Fastigheter SEK109.10, -4.10) -- Q4 earnings

        • -3.2% OLVAS.FH (OLVI €30.25, -1.00) -- Q4 earnings

        • -1.9% DEMANT.DC (Demant DKK262.40, -5.20) -- BofA downgrade

        • -1.0% UCG.IM (UniCredit €46.77, -0.45) -- Q4 earnings; UniCredit CEO comments on rumours of Delfin selling its 2.7% stake -- Sole24Ore citing CNBC

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: voestalpine (VOE.AV), DO & CO (DOC.AV)

        • Belgium: Galapagos (GLPG.NA)

        • Denmark: Genmab (GMAB.DC)

        • Finland: Cargotec (CGCBV.FH), Aktia Bank (AKTIA.FH), Kempower (KEMPOWR.FH), Etteplan (ETTE.FH), Pihlajalinna (PIHLIS.FH), Taaleri (TAALA.FH), Anora Group (ANORA.FH), Remedy Entertainment (REMEDY.FH), NoHo Partners (NOHO.FH), WithSecure Corp. (WITH.FH), Sitowise Group (SITOWS.FH)

        • France: EssilorLuxottica (EL.FP), Compagnie Generale des Etablissements Michelin (ML.FP), Klepierre (LI.FP), Rexel (RXL.FP), Mercialys (MERY.FP)

        • Germany: Siemens Energy (ENR.GR), Carl Zeiss Meditec (AFX.GR), Heidelberger Druckmaschinen (HDD.GR), TeamViewer (TMV.GR), Verbio (VBK.GR)

        • Italy: Telecom Italia (TIT.IM), Banco BPM (BAMI.IM), Italgas (IG.IM)

        • Netherlands: Heineken (HEIA.NA), Koninklijke Ahold Delhaize (AD.NA), ABN AMRO Bank (ABN.NA), Randstad (RAND.NA), Alfen (ALFEN.NA)

        • Norway: Aker BP (AKRBP.NO), Storebrand (STB.NO), Mowi (MOWI.NO), Wallenius Wilhelmsen (WAWI.NO), Entra (ENTRA.NO), BlueNord (BNOR.NO), Wilh. Wilhelmsen Holding (WWI.NO), Elkem (ELK.NO), SATS (SATS.NO), Aker BioMarine (AKBM.NO), Selvaag Bolig (SBO.NO)

        • Spain: Mapfre (MAP.SM)

        • Sweden: Medicover (MCOV.B.SS), Lindab International (LIAB.SS), BioGaia (BIOG.B.SS), Volati (VOLO.SS), Ambea (AMBEA.SS), Storytel (STORY.B.SS), Resurs Holding (RESURS.SS), Catella (CAT.B.SS), Lime Technologies (LIME.SS), Acast (ACAST.SS), Orron Energy (ORRON.SS), Profoto Holding (PRFO.SS), Xspray Pharma (XSPRAY.SS), Nilorngruppen (NIL.B.SS)

        • Switzerland: Schindler Holding (SCHP.SW), DKSH Holding (DKSH.SW)

        • UK: Barratt Redrow (BTRW.LN), TBC Bank Group (TBCG.LN)

  • Data:

    • Economics:

      • France Q4 Unemployment Rate 7.3% vs consensus 7.5% and prior 7.4%

      • Norway Q4 GDP (0.6%) q/q vs consensus +0.6% and prior revised (1.6%) from (1.8%)

    • Markets:

      • WTI Crude (Mar 25): +$0.82 or +1.13% to $73.14

      • €-$ +0.0041 or +0.40% to 1.0348

      • £-$ +0.0053 or +0.43% to 1.2421

      • €-£ (0.0003) to 0.8331

      • S&P 500 (0.03%)

        • Performance year-to-date

        • FTSE 100: +7.39%

        • DAX: +10.69%

        • CAC: +8.78%

        • MIB: +9.93%

        • Stoxx 600: +7.79%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE